About H1N1 vaccine, H1N1vaccine production, H1N1 vaccine manufacturers

Dr. Joseph Bocchini summarizes the CDCs Advisory Committee on Immunization Practices recommendation to replace the current 7-valent pneumococcal conjugate vaccine with the new 13-valent version. Dr. Bocchini is professor of pediatrics and chairman of the department of pediatrics Louisiana State University, Shreveport.
Video Rating: 0 / 5

The Advisory Committee on Immunization Practices expanded their recommendations for the use of pertussis vaccine to adults aged 65 years and older and to children between 7 and 10 years ancient, Dr. Mark H. Sawyer reports.

Related posts:

1. Does Your Baby Need Vaccinations?
2. Protection Against 2009 H1N1 To Be Included in 2010-2011 Seasonal Flu Vaccine